High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$51K
$51,260
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KPTI
S
Karyopharm Therapeutics Inc.
Poulton Stuart
• Officer • EVP, Chief Development Officer
Discretionary Sell
2026-03-02
$47,998
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • EVP, Chief Development Officer
Discretionary Sell
|
2026-03-02 | $47,998 | S | Form 4 |
|
KPTI
S
Karyopharm Therapeutics Inc.
Poulton Stuart
• Officer • EVP, Chief Development Officer
Discretionary Sell
2026-02-17
$3,262
|
||||||
| KPTI |
Karyopharm Therapeutics Inc.
|
Officer • EVP, Chief Development Officer
Discretionary Sell
|
2026-02-17 | $3,262 | S | Form 4 |